by boomer | Jun 15, 2023 | Newsletters
By Jake Steepleton, Rx Product Specialist Situation Spending on GLP-1 drugs which treat Type 2 diabetes and obesity has surged. Weekly prescriptions for OZEMPIC® soared 111% between Feb 2022 to Feb 2023, making it the costliest drug for many employers, surpassing...
by boomer | May 10, 2023 | Newsletters
Situation and Complication The impact of record high inflation will begin hitting health plans in 2023, with costs estimated to rise on average by at least 6.5%. This will lead to higher insurance premiums and more costly care for both employers and employees....
by boomer | May 9, 2023 | Newsletters
Problem Self-insured employers are struggling to rein in the prices they are paying for employee health benefits. The primary strategy to contain costs is to contract with a leading provider network that offers attractive discounts of 60+% for services performed by...
by boomer | May 8, 2023 | Newsletters
Situation and Complication Care navigation is a great concept – helping employees make informed decisions about the best choice for their clinical care. It’s not surprising that most big carriers offer care navigation services or that private equity firms have...
by boomer | May 7, 2023 | Newsletters
Situation and Complication Care navigation is fantastic in concept. Employees generally lack clinical training and therefore don’t know how to properly navigate the health system, e.g., when to go to urgent care versus the emergency department, whether a procedure is...
